A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Local Administration of EXPAREL for Prolonged Postsurgical Analgesia in Subjects Undergoing Third Molar Extraction

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Local Administration of EXPAREL for Prolonged Postsurgical Analgesia in Subjects Undergoing Third Molar Extraction

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Feb 2016

At a glance

  • Drugs Bupivacaine (Primary) ; Lidocaine
  • Indications Dental pain; Postoperative pain
  • Focus Pharmacokinetics; Registrational
  • Sponsors Pacira Pharmaceuticals
  • Most Recent Events

    • 09 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 25 Sep 2015 Planned number of patients changed from 100 to 175, as reported by ClinicalTrials.gov.
    • 12 Aug 2015 No of arms changed from 3 to 2 (all subjects receiving lidocaine 2% with epinephrine is removed) as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top